HEMA Q2 2014 results Unaudited October 2, 2014 Disclaimer By reading this presentation, you are deemed to have read and accepted the statement below. This presentation has been prepared by HEMA B.V. This presentation provides information about HEMA B.V. group and its subsidiaries. Any references to HEMA shall mean HEMA B.V. group and its subsidiaries. While HEMA takes reasonable care to ensure the accuracy of the information in this presentation, it makes no representation or warranty, express or implied, of its accuracy or completeness. This presentation has not been the subject of an audit or a similar investigation. HEMA shall not be held responsible for any direct or indirect losses, damages or liabilities of whatsoever kind arising from the access to, the use of or reliance on this presentation or any of the information it contains. HEMA does not undertake any duty to update or correct such information and reserves the right to change, delete or move any of the material in this presentation at any time without notice. In addition, the information contained in this presentation should not be deemed accurate or current except as of the date of issue. HEMA does not intend to, and does not undertake any duty to, update or correct such information. This presentation may include certain statements, estimates, targets and projections provided by HEMA with respect to the anticipated future performance of HEMA. Such statements, estimates, targets and projections reflect significant assumptions and subjective judgments by HEMA’s management concerning anticipated results. These assumptions and judgments may or may not prove to be correct and there can be no assurance that any estimates, targets or projections are attainable or will be realised. Accordingly, HEMA nor any of their respective directors, partners, employees or advisers nor any other person, shall give any representation or warranty as to the achievements or reasonableness of future projections, estimates or targets nor will they be liable for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on any statement in or omission from this presentation and any such liability is expressly disclaimed. No representation or warranty, express or implied is or will be given by HEMA or its respective affiliates, directors, partners, employees or advisers or any other person as to the accuracy, completeness or fairness of this presentation and, so far as permitted by law and except in the case of fraud by the party concerned, no responsibility or liability whatsoever is accepted for the accuracy or sufficiency thereof or for any errors, omissions or misstatements negligent or otherwise relating thereto. This presentation contains information from other sources (like the CBS, Central Bureau of Statistics) which are not controlled or maintained by HEMA. HEMA is not responsible for the accuracy of this information. The information contained in this presentation is not intended to be and shall not be deemed to be an offer, invitation or inducement to invest in or otherwise deal in any securities of HEMA or in any other investment, nor to provide or constitute any advice or recommendation in connection with any investment decision. The release, publication or distribution of any information or documents on the hemainvestorrelations.com in jurisdictions other than the Netherlands may be restricted by law and therefore persons in a jurisdiction other than the Netherlands into which such information or documents are released, published, distributed or otherwise accessible should inform themselves about and observe any such restrictions. If you require advice, please consult your independent professional financial adviser. The copyright in this presentation belongs to HEMA. All other intellectual property rights are reserved. 2 Introductory remarks Q2 2014 relates to the 13 weeks starting May 5, 2014 and ending August 3, 2014 The Q2 2014 report has been reviewed by PwC On June 17, 2014, HEMA refinanced its existing borrowings As part of its commercial strategy, HEMA began preparation for the remodelling of its Dutch store base during Q2 2014: The remodelling process was initiated in week 25; Resultant disruption to store operations had a negative influence on like-for-like sales and store operating expenditure during the period. In September 2014 (Q3) two franchisees initiated arbitration 3 Contents 1. Economic indicators the Netherlands 2. Macro economic outlook 2014-2015 3. Market developments 4. Q2 2014 results 5. Current trading 6. Commercial update 4 1. Economic indicators In the Netherlands Steady, but fragile recovery of economic indicators Source: CBS, Central Bureau of Statistics, http://www.cbs.nl 6 Steady, but fragile recovery of economic indicators (continued) Source: CBS, Central Bureau of Statistics, http://www.cbs.nl 7 2. Macro economic outlook 2014-2015 the Netherlands GDP and Household consumption 2011 2012 2013 2014 2015 Gross Domestic Product (economic growth in %) 1.7 -1.7 -0.7 0.75 1.25 Household Consumption (%) 0.2 -1.4 -1.6 0.0 1.0 2011 2012 2013 2014 2015 Consumer Price Index (CPI) (% inflation) 2.3 2.5 2.5 1.0 1.25 Contract wages market sector (%) 1.4 1.6 1.2 1.25 1.5 Purchasing power, static, median all households (%) -1.1 -2.1 -1.4 1.5 0.5 2011 2012 2013 2014 2015 389 469 600 620 605 4.4% 5.3% 6.7% 7.0% 6.75% Prices, wages and purchasing power Labour market Unemployment x 1.000 persons % of workforce 9 Source: Macro economic outlook. CPB, Centraal Plan Bureau. http://www.cpb.nl/en/publication/macro-economic-outlook-mev-2015 3. Market developments The Netherlands Dutch Retail: Non Food January - July 2014 vs 2013: Sales Volume Price Source: CBS, Central Bureau of Statistics, http://www.cbs.nl 11 - 0.3% + 0.5% - 0.8% Dutch Retail: Food January - July 2014 vs 2013: Sales Volume Price Source: CBS, Central Bureau of Statistics, http://www.cbs.nl 12 +1.4% +1.2% +0.2% HEMA versus the market HEMA household goods remain under pressure HEMA apparel slightly under pressure, but trend is improving, especially in babywear and bodywear HEMA food in line with market Online outperforming the market HEMA remains best in class on reliability, value for money and good quality Source: third party information 13 4. Q2 2014 results Like-for-like sales Q2 2014 Q2 YTD Period 6 vs 2013 vs 2013 Own Stores Netherlands -4.1% -4.3% Belgium / Luxembourg -1.4% -0.9% Germany -5.3% -4.2% France 8.0% 9.0% Deliveries Franchisees -6.9% -3.8% HEMA -4.6% -3.4% Like for like sales % versus 2013 Negative impact on sales from the remodelling of our directly owned stores in the Netherlands is estimated to be approx. 1 – 2% for Q2 Despite the remodelling in the Netherlands, July 2014 (period 6) witnessed a positive consumer sales development versus last year 15 Headline numbers Q2 2014 Q2 x € Million 2014 YTD period 6 B/W 2013 2014 B/W 2013 Net sales 247.6 -3.4 503.8 -4.8 Gross profit 115.2 1.6 233.0 0.6 -110.9 -7.2 -231.4 -18.6 EBITDA 18.4 -5.4 30.0 -17.1 Adjusted EBITDA 19.4 -5.0 43.1 -5.7 46.5% +120bps 46.2% +50bps Operating expenses Gross profit as % of sales 16 Headline numbers Q2 2014 Q2 2014 EBITDA was € 5.4 million lower versus Q2 2013 (from € 23.8 million to € 18.4 million), due to: Lower sales in the Netherlands, partly due to the remodelling; Q2 2014 gross profit as a percentage of net sales was 120 bps higher versus Q2 2013, mainly as a result of lower markdowns and higher supplier contributions; Q2 2014 operating expenses were € 7.2 million higher versus Q2 2013, mainly due to additional costs as a result of the remodelling process, which are estimated to be approximately € 3.5 million. The remainder is the result of expansion and CPI increases. 17 Cash flow Q2 2014 Q2 x € Million Operating cash before changes in working capital 2014 YTD period 6 B/W 2013 2014 B/W 2013 18.4 -5.4 41.1 -6.0 -10.0 -12.4 1.1 -10.0 -7.9 -7.4 -11.7 -25.3 -34.0 -18.2 -69.6 -17.5 Changes in provisions and other 0.1 2.4 -5.6 -0.2 Income taxes 1.0 -1.4 1.0 0.7 -32.4 -42.4 -43.7 -58.3 Net cash used in investing activities -9.8 3.9 -18.7 13.9 Interest and financial leases -9.0 -0.2 -20.9 -3.6 Borrowings -48.3 -30.0 -48.3 -30.0 Finance fees -14.3 -14.3 -14.3 -14.3 Net cash used in financing activities -71.6 -44.5 -83.5 -47.9 -113.8 -83.0 -145.9 -92.3 Changes in trade & other receivables Changes in inventories Changes in trade & other payables Net cash generated by operating activities Net cash flow 18 Cash flow Q2 2014 Q2 2014 cash flow was lower than Q2 2013, due to: Lower EBITDA; Higher inventories (€ 7.4 million) as a result of the addition of new assortment and leftovers from the mild winter season; Lower trade and other payables (€ 18.2 million), due to lower capital expenditures and changes in payment terms for a specific supplier; Trade and other receivables lower due to timing of payments; Reduction of the borrowings (€ 30.0 million); Finance fees paid (€ 14.3 million) 19 5. Current trading Current trading period 7 (August) In the Netherlands like-for-like sales were almost flat The disruption from the store remodelling had an estimated impact of minus 3% Particular improvement in apparel and catering sales vs last year Lower deliveries to franchisees partly due to remodelling in the franchise stores France continued to deliver double digit like-for-like growth Positive sales development in Belgium 21 Current trading period 8 (September) In period 8 the remodelling process is at its peak: the larger stores are under construction and the smaller stores are in the final stages The impact of remodelling on sales is estimated to be higher than in previous periods (more than -3%) Apparel sales were also under pressure because of a shift in the commercial program and the unusually warm weather in September 22 Current trading period 8 continued Costs are anticipated to be higher due to: More labour hours in the stores (remodelling); Higher sales promotion and other costs to support the relaunch of the remodelled stores The main benefit of the remodelling is expected for P9 to P12 23 Arbitration In September 2014, two franchisees initiated arbitration with the support of the VAB, which is the association of franchisees which represents the collective interest of almost all of HEMA’s franchisees. These two franchisees claim they are entitled to a portion of HEMA’s Marketing Strategy Fund (MSF), which is used for sales promotion and funded by contributions from HEMA suppliers. Based on their own estimates, these two franchisees claim an amount of € 29 million, excluding interest, on behalf of all franchisees over the years 2009 until 2014, and a corresponding share of future MSF contributions. HEMA disputes the validity of the claim and intends to vigorously defend against it. 24 6. Commercial update Webshop award: HEMA best department store and Best in Baby / Kids Ranking best department store: 1. HEMA 2. IKEA 3. BOL.COM 4. Wehkamp 5. V&D Source: ABN AMRO 26 Ranking Baby / Kids: 1. HEMA 2. H&M 3. C&A Remodelling process Substantial operation completed in a very short period of time 520 stores in the Netherlands remodelled over a two months period 330.000 m2 of store space has been reorganised, together with the addition of new assortment to replace lower sales density categories and refresh the “surprise factor” for consumers First impressions remodelling The remodelling process will be completed in week 41 Supported by a large internal promotion program for the relaunch, including new marketing brochures and TV advertising campaigns The relaunch has received a lot of publicity in the Netherlands together with many enthusiastic reactions and compliments from customers Sales increases are anticipated in the coming periods (period 9 to 12) 28 Change of company logo HEMA: “making the ordinary extraordinary” Store presentation New tables New presentation materials Special HEMA favourites logo More attention and maintenance of the tables Favourites - Toys Small toys Creative toys Must haves Puzzles & Games Cooking Living Beauty Improved brochure 35 TV commercial to support new assortment http://www.youtube.com/watch?v=0kI5S4w-rBw&feature=youtu.be 36 Blauwe slide hier invoegen met HEMA maakt bijzonder 37 Questions?
© Copyright 2026 Paperzz